Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Bo Diao; Chenhui Wang; Rongshuai Wang; Zeqing Feng; Yingjun Tan; Huiming Wang; Changsong Wang; Liang Liu; Ying Liu; Yueping Liu; Gang Wang; Zilin Yuan; Liang Ren; Yuzhang Wu; Yongwen Chen

doi:10.1101/2020.03.04.20031120

Summary

BACKGROUND The outbreak of a novel coronavirus (SARS-CoV-2, previously provisionally named 2019 novel coronavirus or 2019-nCoV) since December 2019 in Wuhan, China, has become an emergency of major international concern. Apart from the respiratory system, it is unclear whether SARS-CoV-2 can also directly infect other tissues such as the kidney or induce acute renal failure.

METHODS We conducted a retrospective analysis of estimated glomerular filtration rate (eGFR) along with other clinical parameters from 85 patients with laboratory-confirmed COVID-19 admitted to a hospital in Wuhan from January 17, 2020 to March 3, 2020. Kidney tissues from six patients with postmortem examinations were analyzed by Hematoxylin and Eosin (H&E) and in situ expression of viral nucleocaspid protein (NP) antigen, immune cell markers (CD8, CD68 and CD56) and the complement C5b-9 was detected by immunohistochemistry. Moreover, the viral particles in kidneys were also investigated by transmission electronic microscope (EM).

RESULTS 27.06% (23/85) patients exhibited acute renal failure (ARF). The eldery patients and cases with comorbidities such as hypertension and heart failure more easily developed ARF (65.22% vs 24.19%, p< 0.001; 69.57% vs 11.29%, p< 0.001, respectively). H&E staining demonstrated kidney tissues from postmortems have severe acute tubular necrosis and lymphocyte infiltration. Immunohistochemistry showed that SARS-CoV-2 NP antigen was accumulated in kidney tubules. EM observation also demonstrated that viruses-like particles are visible in the kidneys. Viral infection not only induces CD68⁺ macrophages infiltrated into tubulointerstitium, but also enhances complement C5b-9 deposition on tubules.

CONCLUSIONS SARS-CoV-2 induces ARF in COVID-19 patients. Viruses directly infect human kidney tubules to induce acute tubular damage. The viruses not only have direct cytotoxicity, but also initiate CD68⁺ macrophage together with complement C5b-9 deposition to mediate tubular pathogenesis.

Introduction

In December 2019, a cluster of pneumonia cases caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were reported in Wuhan, Hubei Province, China.^1-3 This disease, now designated as coronavirus disease 2019 (COVID-19) by the WHO, rapidly spread to other cities of China and around the world.^4-6 By March 3, 2020, 80270 cases were laboratory confirmed with 2981 deaths in China based on CCDC (Chinese Center For Disease Control And Prevention) reports.⁷

Some studies have suggested that SARS-CoV-2, SARS-CoV (Severe acute respiratory syndrome-Coronavirus) and MERS-CoV (Middle East Respiratory Syndrome-Coronavirus) share a common ancestor resembling the bat coronavirus HKU9-1.^8,9 Recently, Shi et al., reported that SARS-CoV-2 interacts with human ACE2 (angiotensin converting enzyme-II) molecules via its Spike protein.¹⁰ In addition to respiratory organs, the expression of ACE2 protein has also been observed in human kidneys,^11,12 and Cheng et al., reported that some COVID-19 patients had an elevated level of proteinuria.¹³ However, no evidence directly demonstrates that SARS-CoV-2 can infect the kidney to cause acute renal failure.

We retrospectively analyzed the clinical data on kidney function from 85 cases of COVID-19 who were admitted into the General Hospital of Central Theatre Command in Wuhan, Hubei Province, from January 17, 2020 to March 3, 2020. To elucidate the mechanism of renal injury, we also used H&E staining and immunohistochemistry to visually assess tissue damage and viral presence in kidney tissues from six biopsies.

Methods

Patients

Medical records from 85 COVID-19 patients (aged from 21 years to 92 years) with dynamic observation of renal function in General Hospital of Central Theatre Command in Wuhan from January 17, 2020 to March 3, 2020 were collected and retrospectively analyzed. Postmortem autopsies were conducted on six patients who had been admitted in Hospital. Diagnosis of COVID-19 was based on the New Coronavirus Pneumonia Prevention and Control Program (5^th edition) published by the National Health Commission of China. All the patients were laboratory-confirmed positives for SARS-CoV-2 by use of quantitative RT-PCR (qRT-PCR) on throat swab samples. This study was approved by the National Health Commission of China and Ethics Commission of General Hospital of Central Theatre Command ([2020]017-1) and Jinyintan Hospital (KY-2020-15.01). Written informed consent was waived by the Ethics Commission of the designated hospital for emerging infectious diseases.

Data collection and definitions

We reviewed clinical records and laboratory findings for all the patients. All information was obtained and curated with a customized data collection form. eGFR was calculated by the CKD-EPI equation based on serum creatinine level, sex, race and age. Acute renal impairment was defined as a decline of eGFR by at least 30% of the baseline value on admission or below 90mL/min on admission. Three investigators (C Wang, Z Fen and Y Chen) independently reviewed the data collection forms to verify data accuracy.

Tissue morphology detection and immunohistochemistry

Due to the special infection-control precaution of handling deceased subjects with COVID-19, postmortem examination was performed in a designated pathology laboratory. Kidney specimens from autopsy were retrieved for standard examination via light microscopy. Briefly, paraffin-embedded tissue blocks were cut into 3 μm slices and mounted onto poly-lysine-coated glass slides, and tissue injury was stained for by H&E. Sections were also used for immunohistochemistry as following: Antigen retrieval was performed by microwaving these sections in citrate buffer (10 mM, pH□6.0). The sections were then incubated in 3% BSA plus 0.1% H2O2 for 1h at RT to block nonspecific binding. The sections were then incubated overnight at 4 °C with primary anti-SARS-CoV-2 nucleocaspid protein (NP) antibodies (clone ID: 019, 1:100, rabbit IgG; Sino Biological, Beijing), anti-CD8 (Clone ID:4B11, 1:100, mouse IgG2b; BIO-RAD), anti-CD68 (Clone ID:KP1, 1:100, mouse IgG1; BIO-RAD), anti-CD56 (Clone ID:123C3, 1:100, mouse IgG1; BIO-RAD), anti-C5b-9 (clone ID: aE11, 1:100, mouse IgG; Dakocytomation) or rabbit-isotype antibody controls (1:100; Dako). Sections were further incubated with the HRP-anti-Rabbit secondary antibodies for 1h at RT. Peroxidase activity was visualized with the DAB Elite kit (K3465, DAKO), and the brown coloration of tissues represented positive staining as viewed by a light microscope (Zeiss Axioplan 2, Germany).

Transmission electron microscopy

Two kidneys from 2 cases of autopsy were collected and fixed with 2.5% glutaraldehyde in phosphoric buffer (pH 7.4), post-fixed with 1% osmate, dehydrated with gradient alcohol, embedded in Epon 812, double-stained with uranium acetate and lead citromalic acid. The virus-like particles were observed under a JEM1200 transmission electron microscope (Jeol, Tokyo, Japan).

Statistical analysis

Statistical analyses were performed using GraphPad Prism version 8.0 (GraphPad Software, Inc., San Diego, CA, USA). Categorical variables were expressed as numbers (%). p values are from χ2.

Role of the funding source

The funding agencies did not participate in study design, data collection, data analysis, or manuscript writing. The corresponding authors were responsible for all aspects of the study to ensure that issues related to the accuracy or integrity of any part of the work were properly investigated and resolved. The final version was approved by all authors.

Results

1. SARS-CoV-2 induces ARF in COVID-19 patients

We retrospectively analyzed laboratory kidney functions from 85 cases of COVID-19 patients, and focusing on eGFR. Results showed that 27.06% (23/85) COVID-19 patients exhibited acute renal failure. Patients who are elderly (≥60 years) or carry comorbidities (65.22% vs 24.19%, p<0.001, 69.57% vs 11.29%, p<0.001, respectively), such as hypertension (39.13% vs 12.90%, p=0.0007) and coronary heart disease (21.74% vs 4.84%, p=0.018) more easily developed ARF (Table1), suggesting renal function impairment is relatively common in COVID-19 patients.

View this table:

Table 1.

Clinical Characteristics of COVID-19 patients.

2. SARS-CoV-2 induces human kidney tubular injury

Next, the histopathological examination was performed by H&E-staining in kidney specimens from autopsy of six COVID-19 subjects with observed renal function impairment. Varying degrees of acute tubular necrosis, luminal brush border sloughing and vacuole degeneration, were found in different areas of all six renal specimens. Severe infiltration of lymphocytes in the tubulointerstitium was observed in two patients, and moderate infiltration was seen in three cases, and the remaining one case manifested absence of lymphocyte infiltration. Moreover, viral infection associated-syncytia were also observed in three cases. At the same time, dilated capillary vessels were observed in the glomeruli of these 6 cases. Nevertheless, severe glomerular injury was absent in all of these six cases, although benign hypertensive glomerulosclerosis and autolysis were noted in three hypertensive patients (Figure 1, Table 2). Collectively, these results demonstrated that SARS-CoV-2 infection mainly induces severe acute tubular necrosis and lymphocyte infiltration.

View this table:

Table 2.

The pathologic findings and protein expression of kidney tissues from COVID-19 patients undergoing postmortem examintion.

Figure 1. Representative H&E staining of kidney tissues from 6 cases of COVID-19 patients undergoing postmortem examination.

Sections were stained by H&E, arrow indicated infiltrated lymphocytes; arrow head indicated viral infection associated-syncytia. Scale bar= 100 μM.

3. SARS-CoV-2 directly infects human kidney tubules

To confirm that SARS-CoV-2 might directly infect kidney tubules thus lead to tubular damage, the viral NP antigen was assessed by immunohistochemistry. Results showed that SARS-CoV-2 NP antigens could be seen in kidney tissues from all of these six samples, with NP expression restricted to kidney tubules, and NP-positive inclusion body was also observed. The NP-positive expression was observed in cytoplasm, but nuclear signals were not observed (Figure 2A). Some NP-positive tubular epithelial cells were dropped from normal tubules (Figure 2B), while NP-antigen was also absent in the glomerulus (Figure 2C). The expression of NP protein in lung tissues from COVID-19 patients was used as positive controls (Figure 2D), whereas normal kidney tissues (Figure 2E) or renal sections from unrelated autopsies treated with rabbit isotype control antibodies (Figure 2F) were used as negative controls. Collectively, these data suggest that SARS-CoV-2 directly infects kidney tubules.

Figure 2. Immunohistochemistry analyzed SARS-CoV-2 NP antigen in kidney tissues.

The expression of viral NP antigen was detected in kidney (A∼C) and lung (D) tissues from COVID-19 patients undergoing postmortem examination. A: arrow indicated NP positive tubules and arrow head indicated viral inclusion body. B: arrow indicated viral NP positive cells dropped from normal tubule; C: arrow indicated NP positive cells and circle indicated glomerulus; E: Absence expression of viral NP protein in normal kidney tissues; F: Sections incubated with rabbit IgG1 isotype control antibodies. Scale bar= 100 μM.

4. Direct observation of virus-like particles in kidneys by EM

Transmission electron microscopy (EM) was used to detect virions and virus-like particles in two kidneys from two autopsies. The results showed that cells in infected renal tissues were markedly swollen with expansion of mitochondria and lysosomes. The rough endoplasmic reticulum (RER) and smooth endoplasmic reticulum (SER) are also dilated greatly. Interestingly, viruses-like particles with 80∼160 nm diameters are observed in the broken lysosomes in cytoplasm, clearly identifiable due to high electron density and complete coating (Figure 3). Moreover, virus-like particles are all seen in both cases, demonstrating SARS-CoV-2 directly infects kidneys.

Figure 3. The virus-like particles are observed in kidney by EM.

EM was used to detect virions in two kidney tissues from two autopsies, and viruses-like particles with 80∼160 nm diameters are observed in the broken lysosomes in cytoplasm, clearly identifiable due to high electron density and complete coating. Arrow indicated virus-like particles.

5. SARS-CoV-2 induces CD68⁺ macrophage infiltration and complement C5b-9 deposition

Since the infiltration of proinflammatory cells can significantly accelerate tubular damage, we next examined the identity of these infiltrated cells. Immunohistochemistry showed strong presence of CD68⁺ macrophages were in the tubulointerstitium of these six cases, while moderate numbers of CD8⁺ T cells were also observed in two cases, whereas, CD4⁺ T cells and CD56⁺ natural killer (NK) cells were seldom found in the examined tissues (Figure 4A, Table 2), suggesting that SARS-CoV-2 might cause further tubular damage through recruiting macrophages to infiltrate into the tubulointerstitium.

Figure 4. Immunohistochemistry analyzed lymphocytes and the complement C5b-9 in kidney tissues.

The expression of (A) CD68, CD8 and CD56; (B) C5b-9 in kidney tissues from COVID-19 patients undergoing postmortem examination or normal healthy was detected by immunohistochemistry. Arrow indicated positive cells. Scale bar= 100 μM.

As the deposition of the complement membrane-attack complex (MAC, also named C5b-9) on tubules or glomeruli may also cause renal damage,¹⁴ we further analyzed C5b-9 status in kidney tissues from these postmortems. Interestingly, strong C5b-9 depositions on tubules were observed in all of these six cases. Very low levels of C5b-9 deposition on glomeruli and capillaries were also seen in two cases. However, C5b-9 expression is absent in normal kidney tissue (Figure 4B, Table 2), suggesting that SARS-CoV-2 infection induces acute tubular necrosis and ARF through triggering C5b-9 deposition.

Discussion

In this study, we found that 27.06% of patients with COVID-9 had abnormal eGFR, and patients who are aged or have comorbidities more commonly developed ARF (Table 1), suggesting that ARF is relatively common following SARS-CoV-2 infection. This phenomenon is different from the 2003 outbreak of SARS, in which ARF was uncommon, despite being one of the top risk factors for mortality.¹⁵ Recently, Yan et al., reported that 63% (32/51) of COVID-19 patients had an elevated level of proteinuria.¹³ Collectively, these results illustrate that SARS-CoV-2 mediated ARF may be one of the major causes of multiorgan failure and eventual death in COVID-19 patients.

The extents of tubular atrophy and interstitial disease are the strongest histological parameters which correlate with renal function and predict progression. To further analyze how SARS-CoV-2 affects renal function, we focused on analyzing renal tissue morphology from autopsies. H&E staining showed that acute renal tubular damage and lymphocyte infiltration was observed in all six cases during postmortem examinations, while the glomeruli were intact, except for some cases with slight glomerulosclerosis, suggesting that other conditions such as hypertension and diabetic nephropathy may have been involved in the pathogenesis(Figure 1). It has been shown that the ACE-2 receptor of SARS-CoV-2 is highly expressed in renal tubules.^12,16 We used immunohistochemistry to analyze the expression of viral NP antigen in situ in kidney tissues, and found that viral NP antigen was restricted to the renal tubular cells of the infected tissues (Figure 2). Most important, EM observation demonstrated that viruses-like particles are also visible in the infected kidneys (Figure 3). This phenomenon is consistent with SARS-CoV and MERS-CoV, both of which can also infect human kidneys.^17,18 Recently, some researchers have reported they have successfully isolated SARS-CoV-2 virus particles from the urine of COVID-19 patients, suggesting that kidney-originated viral particles may enter the urine through glomerular filtration. Taken together with our study, these results demonstrate that the kidney is also a site of viral infection and replication outside of the lungs.

While SARS-CoV-2 is a cytopathic virus which can also directly induce renal tubular injury during infection and replication, the occurrence of such injury may also initiate complex immune responses. After all, although host immune cells can infiltrate into infected tissue to counteract viral replication, hyperactivation of immune cells may instead promote fibrosis, induce epithelial cell apoptosis, and cause microvasculature changes.^19-21 We report here that SARS-CoV-2 virus recruits high levels of CD68⁺ macrophages to infiltrate into the tubulointerstitium (Figure 4A), suggesting that proinflammatory cytokines derived from macrophages would induce tubular damage. Both clinical and experimental models suggest that the abnormal presence of serum-derived complement components in the tubular lumen leads to the assembly of the complement C5b-9 (via the alternative pathway) on the apical brush border of tubular epithelial cells (TECs), and that this is an important factor in the pathogenesis of tubulointerstitial damage.^22-24 We here observed that SARS-CoV-2 initiates complement C5b-9 assembly and deposition on tubules (Figure 4B). We therefore demonstrate that SARS-CoV-2 causes tubular damage through direct cytotoxicity, but also initiates immune-mediates tubule pathogenesis.

In conclusion, we have demonstrated that the SARS-CoV-2 virus can directly infect human renal tubules and consequently lead to acute renal tubular injury. Moreover, improvement of eGFR would increase the survival of COVID-19 patients who have ARF. We strongly suggest that applying potential interventions including continuous renal replacement therapies (CRRT) for protecting kidney function in COVID-19 patients, particularly for ARF cases, maybe a key method to preventing fatality.

Conflict of interest

The authors declare no financial or commercial conflict of interest.

Authors’ contributions

Yuzhang Wu, and Yongwen Chen were involved in the final development of the project and manuscript preparation; Zilin Yuan, Chenghui Wang and Zeqing Feng analyzed the data; Chenghui Wang did EM experiments; Bo Diao and Huiming Wang performed most of experiments; Yin Liu, Gang Wang, Yinjun Tan and Yueping Liu did H&E staining and immunohistochemistry; Changsong Wang evaluated H&E and immunohistochemistry results; Liang Liu, Rongshuai Wang and Liang Ren provided autopsies and analyzed H&E staining.

Ethics committee approval

This study was approved by the National Health Commission of China and Ethics Commission of General Hospital of Central Theatre Command and Jinyintan Hospital.

References

1.↵
Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020.
Google Scholar
2.
Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med 2020.
Google Scholar
3.↵
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020.
Google Scholar
4.
Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020.
Google Scholar
5.
Bernard SS, Rolland P, Silue Y, et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro surveillance: bulletin Europeen sur les maladies transmissibles= European communicable disease bulletin 2020; 25(6).
Google Scholar
6.
Cheng S-C, Chang Y-C, Chiang Y-LF, et al. First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan. Journal of the Formosan Medical Association 2020.
Google Scholar
7.↵
National Health Commission of the People’s Republic of China. The latest situation of novel coronavirus pneumonia as of 24:00 on 3 March, 2020. http://www.xinhuanet.com/politics/2020-03/04/c_1125659905.htm Date accessed: March 4, 2020.
Google Scholar
8.↵
Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China Life Sciences 2020: 1–4.
Google Scholar
9.↵
Chan JF-W, Kok K-H, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes & Infections 2020; 9(1): 221–36.
OpenUrl Google Scholar
10.↵
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020.
Google Scholar
11.↵
Lin W, Hu L, Zhang Y, et al. Single-cell Analysis of ACE2 Expression in Human Kidneys and Bladders Reveals a Potential Route of 2019-nCoV Infection. bioRxiv 2020.
Google Scholar
12.↵
Fan C, Li K, Ding Y, Lu WL, Wang J. ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection. medRxiv 2020.
Google Scholar
13.↵
Cheng Y, Luo R, Wang K, et al. Kidney impairment is associated with in-hospital death of COVID-19 patients. medRxiv 2020.
Google Scholar
14.↵
Takano T, Elimam H, Cybulsky AV. Complement-mediated cellular injury. Seminars in nephrology; 2013: Elsevier; 2013. p. 586–601.
Google Scholar
15.↵
Chu KH, Tsang WK, Tang CS, et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney international 2005; 67(2): 698–705.
OpenUrl CrossRef PubMed Web of Science Google Scholar
16.↵
Lely A, Hamming I, van Goor H, Navis G. Renal ACE2 expression in human kidney disease. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland 2004; 204(5): 587–93.
OpenUrl Google Scholar
17.↵
Ding Y, He L, Zhang Q, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARSLJCoV) in SARS patients: implications for pathogenesis and virus transmission pathways. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland 2004; 203(2): 622–30.
OpenUrl Google Scholar
18.↵
Poissy J, Goffard A, Parmentier-Decrucq E, et al. Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases. Journal of Clinical Virology 2014; 61(2): 275–8.
OpenUrl CrossRef PubMed Google Scholar
19.↵
Meng X-M, Nikolic-Paterson DJ, Lan HY. Inflammatory processes in renal fibrosis. Nature Reviews Nephrology 2014; 10(9): 493–503.
OpenUrl Google Scholar
20.
Saffarzadeh M, Juenemann C, Queisser MA, et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PloS one 2012; 7(2).
Google Scholar
21.↵
Pober JS, Sessa WC. Inflammation and the blood microvascular system. Cold Spring Harbor perspectives in biology 2015; 7(1): a016345.
OpenUrl Abstract/FREE Full Text Google Scholar
22.↵
Biancone L, David S, Della Pietra V, Montrucchio G, Cambi V, Camussi G. Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney international 1994; 45(2): 451–60.
OpenUrl CrossRef PubMed Web of Science Google Scholar
23.
Cybulsky AV, Takano T, Papillon J, Khadir A, Liu J, Peng H. Complement C5b-9 membrane attack complex increases expression of endoplasmic reticulum stress proteins in glomerular epithelial cells. Journal of Biological Chemistry 2002; 277(44): 41342–51.
OpenUrl Abstract/FREE Full Text Google Scholar
24.↵
David S, Biancone L, Caserta C, Bussolati B, Cambi V, Camussi G. Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association 1997; 12(1): 51–6.
OpenUrl Google Scholar

Posted April 10, 2020.

Download PDF

Author Declarations

Data/Code

Citation Tools

Get QR code

Tweet Widget

Subject Area

Infectious Diseases (except HIV/AIDS)

Reviews and Context

Comment

TRIP Peer Reviews

Community Reviews

Automated Services

Blogs/Media

Author Videos

Subject Areas

All Articles

Addiction Medicine (412)
Allergy and Immunology (726)
Anesthesia (214)
Cardiovascular Medicine (3095)
Dentistry and Oral Medicine (349)
Dermatology (261)
Emergency Medicine (463)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1099)
Epidemiology (13033)
Forensic Medicine (13)
Gastroenterology (861)
Genetic and Genomic Medicine (4855)
Geriatric Medicine (449)
Health Economics (751)
Health Informatics (3062)
Health Policy (1106)
Health Systems and Quality Improvement (1133)
Hematology (410)
HIV/AIDS (960)
Infectious Diseases (except HIV/AIDS) (14341)
Intensive Care and Critical Care Medicine (883)
Medical Education (453)
Medical Ethics (120)
Nephrology (500)
Neurology (4618)
Nursing (244)
Nutrition (688)
Obstetrics and Gynecology (844)
Occupational and Environmental Health (764)
Oncology (2389)
Ophthalmology (675)
Orthopedics (270)
Otolaryngology (333)
Pain Medicine (301)
Palliative Medicine (87)
Pathology (515)
Pediatrics (1242)
Pharmacology and Therapeutics (520)
Primary Care Research (522)
Psychiatry and Clinical Psychology (3968)
Public and Global Health (7197)
Radiology and Imaging (1606)
Rehabilitation Medicine and Physical Therapy (955)
Respiratory Medicine (943)
Rheumatology (459)
Sexual and Reproductive Health (477)
Sports Medicine (403)
Surgery (513)
Toxicology (65)
Transplantation (221)
Urology (189)

Comments

medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions and read our Comment Policy before commenting. The content of a comment is not endorsed by medRxiv.

View 2 comments on earlier versions of this paper

medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors.

Community reviews for this article:

There are no community reviews for this paper.

Automated Evaluations

Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv.

Automated Evaluations:

There are no automated evaluations for this paper.

[1] 1.↵
Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020.
Google Scholar

[2] 2.
Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med 2020.
Google Scholar

[3] 3.↵
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020.
Google Scholar

[4] 4.
Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020.
Google Scholar

[5] 5.
Bernard SS, Rolland P, Silue Y, et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro surveillance: bulletin Europeen sur les maladies transmissibles= European communicable disease bulletin 2020; 25(6).
Google Scholar

[6] 6.
Cheng S-C, Chang Y-C, Chiang Y-LF, et al. First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan. Journal of the Formosan Medical Association 2020.
Google Scholar

[7] 7.↵
National Health Commission of the People’s Republic of China. The latest situation of novel coronavirus pneumonia as of 24:00 on 3 March, 2020. http://www.xinhuanet.com/politics/2020-03/04/c_1125659905.htm Date accessed: March 4, 2020.
Google Scholar

[8] 8.↵
Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China Life Sciences 2020: 1–4.
Google Scholar

[9] 9.↵
Chan JF-W, Kok K-H, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes & Infections 2020; 9(1): 221–36.
OpenUrl Google Scholar

[10] 10.↵
Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020.
Google Scholar

[11] 11.↵
Lin W, Hu L, Zhang Y, et al. Single-cell Analysis of ACE2 Expression in Human Kidneys and Bladders Reveals a Potential Route of 2019-nCoV Infection. bioRxiv 2020.
Google Scholar

[12] 12.↵
Fan C, Li K, Ding Y, Lu WL, Wang J. ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection. medRxiv 2020.
Google Scholar

[13] 13.↵
Cheng Y, Luo R, Wang K, et al. Kidney impairment is associated with in-hospital death of COVID-19 patients. medRxiv 2020.
Google Scholar

[14] 14.↵
Takano T, Elimam H, Cybulsky AV. Complement-mediated cellular injury. Seminars in nephrology; 2013: Elsevier; 2013. p. 586–601.
Google Scholar

[15] 15.↵
Chu KH, Tsang WK, Tang CS, et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney international 2005; 67(2): 698–705.
OpenUrl CrossRef PubMed Web of Science Google Scholar

[16] 16.↵
Lely A, Hamming I, van Goor H, Navis G. Renal ACE2 expression in human kidney disease. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland 2004; 204(5): 587–93.
OpenUrl Google Scholar

[17] 17.↵
Ding Y, He L, Zhang Q, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARSLJCoV) in SARS patients: implications for pathogenesis and virus transmission pathways. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland 2004; 203(2): 622–30.
OpenUrl Google Scholar

[18] 18.↵
Poissy J, Goffard A, Parmentier-Decrucq E, et al. Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases. Journal of Clinical Virology 2014; 61(2): 275–8.
OpenUrl CrossRef PubMed Google Scholar

[19] 19.↵
Meng X-M, Nikolic-Paterson DJ, Lan HY. Inflammatory processes in renal fibrosis. Nature Reviews Nephrology 2014; 10(9): 493–503.
OpenUrl Google Scholar

[20] 20.
Saffarzadeh M, Juenemann C, Queisser MA, et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PloS one 2012; 7(2).
Google Scholar

[21] 21.↵
Pober JS, Sessa WC. Inflammation and the blood microvascular system. Cold Spring Harbor perspectives in biology 2015; 7(1): a016345.
OpenUrl Abstract/FREE Full Text Google Scholar

[22] 22.↵
Biancone L, David S, Della Pietra V, Montrucchio G, Cambi V, Camussi G. Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney international 1994; 45(2): 451–60.
OpenUrl CrossRef PubMed Web of Science Google Scholar

[23] 23.
Cybulsky AV, Takano T, Papillon J, Khadir A, Liu J, Peng H. Complement C5b-9 membrane attack complex increases expression of endoplasmic reticulum stress proteins in glomerular epithelial cells. Journal of Biological Chemistry 2002; 277(44): 41342–51.
OpenUrl Abstract/FREE Full Text Google Scholar

[24] 24.↵
David S, Biancone L, Caserta C, Bussolati B, Cambi V, Camussi G. Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association 1997; 12(1): 51–6.
OpenUrl Google Scholar

Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Summary

Introduction